{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:11:16Z","timestamp":1791889876595,"version":"4.3.4"},"reference-count":114,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.bmc.2004.05.045","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T08:07:31Z","timestamp":1103184451000},"page":"6331-6342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Corticosteroids: the mainstay in asthma therapy"],"prefix":"10.1016","volume":"12","author":[{"given":"Ranju","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharam Paul","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2004.05.045_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1358\/dot.1998.34.3.485166","article-title":"Bronchodilators and corticosteroids in the treatment of asthma","volume":"34","author":"Vianna","year":"1998","journal-title":"Drugs Today"},{"key":"10.1016\/j.bmc.2004.05.045_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00008480-200010000-00003","article-title":"Prevention of asthma morbidity: recent advances","volume":"12","author":"Zorc","year":"2000","journal-title":"Cur. Opin. Pediatr."},{"issue":"5","key":"10.1016\/j.bmc.2004.05.045_bib3","first-page":"270","article-title":"Future trends in asthma therapy","volume":"2","author":"Szelenyi","year":"1989","journal-title":"DN&P"},{"key":"10.1016\/j.bmc.2004.05.045_bib4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1378\/chest.119.5.1533","article-title":"The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma","volume":"119","author":"Salvi","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.bmc.2004.05.045_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2165\/00063030-200115040-00004","article-title":"Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma","volume":"15","author":"Smith","year":"2001","journal-title":"Biodrugs"},{"key":"10.1016\/j.bmc.2004.05.045_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.104.5.1565","article-title":"What role for inhaled steroids in chronic asthma","volume":"104","author":"Busse","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.bmc.2004.05.045_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1081-1206(10)62306-X","article-title":"Efficacy of antileukotriene agents in asthma management","volume":"86","author":"Nathan","year":"2001","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.bmc.2004.05.045_bib8","first-page":"295","article-title":"Prospects for the development of new drugs for the therapy of respiratory diseases","volume":"32","author":"Whelan","year":"1996","journal-title":"Drugs Today"},{"key":"10.1016\/j.bmc.2004.05.045_bib9","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198911303212206","article-title":"A new approach to the treatment of asthma","volume":"321","author":"Barnes","year":"1989","journal-title":"New Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bmc.2004.05.045_bib10","first-page":"475","article-title":"Recent perspectives in the design of antiasthmatic agents","volume":"55","author":"Prasad","year":"2000","journal-title":"Pharmazie"},{"issue":"6","key":"10.1016\/j.bmc.2004.05.045_bib11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1034\/j.1399-3003.2000.16f24.x","article-title":"New immunological approaches and cytokine targets in asthma and allergy","volume":"16","author":"Starling","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bmc.2004.05.045_bib12","series-title":"Mast Cell Involvement in Asthma","author":"Shimizu","year":"1997"},{"key":"10.1016\/j.bmc.2004.05.045_bib13","first-page":"13","article-title":"Asthma treatment pharmacological principles and mechanisms of drug action","volume":"10","author":"Svedmyr","year":"1977","journal-title":"Scand. J. Respir. Dis."},{"key":"10.1016\/j.bmc.2004.05.045_bib14","series-title":"Glucocorticoids and Mechanisms of Asthma","first-page":"17","article-title":"Development of Glucocorticosteroids with Lung Selectivity","author":"Brattsand","year":"1988"},{"key":"10.1016\/j.bmc.2004.05.045_bib15","series-title":"Burger\u2019s Medicinal Chemistry and Drug Discovery","first-page":"511","article-title":"Antiallergic Agents","author":"Connor","year":"1996"},{"key":"10.1016\/j.bmc.2004.05.045_bib16","series-title":"Drugs and the Lung","first-page":"101","article-title":"Current Drugs for Respiratory Diseases, Glucocorticoids","author":"Brattsand","year":"1994"},{"key":"10.1016\/j.bmc.2004.05.045_bib17","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1164\/ajrccm\/147.5.1306","article-title":"Dosages of corticosteroids in asthma","volume":"147","author":"McFadden","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.bmc.2004.05.045_bib18","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1021\/jm9604639","article-title":"Anti-inflammatory 17\u03b2-Thioalkyl-16\u03b1,17\u03b1-ketal and -acetal androstanes: a new class of airway selective steroids for the treatment of asthma","volume":"39","author":"Ashton","year":"1996","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bmc.2004.05.045_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1081\/JAS-120017980","article-title":"Inhaled corticosteroids for asthma: common clinical quandaries","volume":"40","author":"Parameswaran","year":"2003","journal-title":"J. Asthma"},{"key":"10.1016\/j.bmc.2004.05.045_bib20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0025-7125(02)00032-9","article-title":"The use of inhaled corticosteroids in adults asthma","volume":"86","author":"Staresinic","year":"2002","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.bmc.2004.05.045_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ppul.10040","article-title":"Safety of inhaled corticosteroids in children","volume":"33","author":"Allen","year":"2002","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.bmc.2004.05.045_bib22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1006\/pupt.2002.0397","article-title":"Inhaled corticosteroids (budesonide): the cornerstone of asthma therapy\u2014what are the options?","volume":"15","author":"Angus","year":"2002","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bmc.2004.05.045_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5694\/j.1326-5377.2003.tb05167.x","article-title":"Inhaled corticosteroid doses in asthma: an evidence based approach","volume":"178","author":"Powell","year":"2003","journal-title":"Med. J. Aust."},{"issue":"3","key":"10.1016\/j.bmc.2004.05.045_bib24","first-page":"101","article-title":"Anti-allergic drugs","volume":"22","author":"Tasaka","year":"1986","journal-title":"Drugs Today"},{"key":"10.1016\/j.bmc.2004.05.045_bib25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1358\/dof.1997.022.08.418850","article-title":"Methylprednisolone suleptanate","volume":"22","author":"Graul","year":"1997","journal-title":"Drugs Future"},{"issue":"2","key":"10.1016\/j.bmc.2004.05.045_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-199753020-00006","article-title":"Triamcinolone acetonide: a review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis","volume":"53","author":"Jeal","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2004.05.045_bib27","first-page":"597","article-title":"Beclomethasone dipropionate in chronic asthma","volume":"23","author":"Cox","year":"1989","journal-title":"DICP Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.bmc.2004.05.045_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1378\/chest.112.1.34","article-title":"A comparison of double-strength beclomethasone dipropionate (84mcg) with beclomethasone dipropionate (42mcg) MDI in the treatment of asthma","volume":"112","author":"Nathan","year":"1997","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.bmc.2004.05.045_bib29","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2165\/00003495-199600526-00003","article-title":"Clinical management of asthma in 1990s: current therapy and new directions","volume":"52","author":"Jain","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2004.05.045_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/j.1552-4604.1997.tb04263.x","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of systemic effects of flunisolide after inhalation","volume":"37","author":"Mollmann","year":"1997","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bmc.2004.05.045_bib31","first-page":"287","article-title":"Clinical data of fluocortin butyl ester (FCB)\u2014a new inhalable corticosteroid","volume":"157","author":"Chen-Walden","year":"1981","journal-title":"Z. Erkr Atmungsorgane"},{"key":"10.1016\/j.bmc.2004.05.045_bib32","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0149-2918(03)80108-X","article-title":"Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma","volume":"25","author":"Corren","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bmc.2004.05.045_bib33","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/jm00169a004","article-title":"Synthesis and antiinflammatory activity of novel 12\u03b2-substituted analogues of betamethasone","volume":"33","author":"Avery","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2004.05.045_bib34","first-page":"1787","volume":"36","author":"Lutsky","year":"1986","journal-title":"Arzneim-Forsch."},{"key":"10.1016\/j.bmc.2004.05.045_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0039-128X(84)90028-X","article-title":"Systemic effects of chronically administered methyl prednisolonate and methyl 17-deoxy prednisolonate","volume":"43","author":"Olejniczak","year":"1984","journal-title":"Steroids"},{"key":"10.1016\/j.bmc.2004.05.045_bib36","first-page":"577","article-title":"Anti-inflammatory steroids: research trends and new compounds","volume":"25","author":"Lee","year":"1989","journal-title":"Drugs Today"},{"key":"10.1016\/j.bmc.2004.05.045_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0022-4731(74)90160-5","article-title":"Antiinflammatory esters of steroidal carboxylic acids","volume":"5","author":"Bain","year":"1974","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bmc.2004.05.045_bib38","series-title":"Medicinal Chemistry. The Role of Organic Chemistry in Drug Research","first-page":"167","article-title":"Discovery of a Family of Potent Topical Anti-inflammatory Agents","author":"Elks","year":"1985"},{"key":"10.1016\/j.bmc.2004.05.045_bib39","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1021\/jm00048a008","article-title":"Synthesis and structure\u2013activity relationships in a series of antiinflammatory corticosteroid analogues, halomethyl androstane-17\u03b2-carbothioates and -17\u03b2-carboselenoates","volume":"37","author":"Phillipps","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2004.05.045_bib40","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2165\/00003495-199243050-00009","article-title":"Intranasal fluticasone propionate","volume":"43","author":"Bryson","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2004.05.045_bib41","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trials","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.bmc.2004.05.045_bib42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bmj.327.7420.891","article-title":"Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomized, comparative trial","volume":"327","author":"Bjermer","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.bmc.2004.05.045_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00003495-199244030-00007","article-title":"Budesonide: an updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis","volume":"44","author":"Brogden","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2004.05.045_bib44","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jaci.2003.12.055","article-title":"Dose-dependent effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis (SAR)","volume":"113","author":"Ratner","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bmc.2004.05.045_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1094-5539(03)00105-6","article-title":"Soft steroids: a new approach to the treatment of inflammatory airways disease","volume":"6","author":"Belvisi","year":"2003","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bmc.2004.05.045_bib46","series-title":"Goodman and Gilman\u2019s, the Pharmacological Basis of Therapeutics","first-page":"733","article-title":"Drugs Used in the Treatment of Asthma","author":"Undem","year":"2001"},{"key":"10.1016\/j.bmc.2004.05.045_bib47","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1034\/j.1398-9995.2003.00162.x","article-title":"Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis","volume":"58","author":"Stuck","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.bmc.2004.05.045_bib48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0022-4731(87)90384-0","article-title":"The mechanism of [3H]-dexamethasone uptake into prolactin producing rat pituitary cells (GH3 cells) in cultures","volume":"28","author":"Furu","year":"1987","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bmc.2004.05.045_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00000441-200003000-00006","article-title":"Southwestern Internal Medicine Conference: Syndromes of Severe Asthma","volume":"319","author":"Weissler","year":"2000","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bmc.2004.05.045_bib50","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm\/148.4_Pt_2.S1","article-title":"Efficacy and safety of inhaled corticosteroids in asthma","volume":"148","author":"Barnes","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.bmc.2004.05.045_bib51","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1210\/endo-120-4-1232","article-title":"Intracellular localisation of glucocorticoid receptor: evidence for cytoplasmic and nuclear localization","volume":"120","author":"Wikstorm","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.bmc.2004.05.045_bib52","first-page":"A628","article-title":"Glucocorticoid receptor mRNA localization and expression in human lung (abstract)","volume":"143","author":"Adcock","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.bmc.2004.05.045_bib53","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1016\/S0021-9258(18)83689-4","article-title":"Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor","volume":"264","author":"Bresnick","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2004.05.045_bib54","doi-asserted-by":"crossref","first-page":"24601","DOI":"10.1016\/S0021-9258(18)54271-X","article-title":"Protein components of the nonactivated glucocorticoid receptor","volume":"266","author":"Rexin","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2004.05.045_bib55","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.1376003","article-title":"Association of 59-kDa immunophillin with the glucocorticoid receptor complex","volume":"256","author":"Albers","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bmc.2004.05.045_bib56","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0092-8674(88)90122-5","article-title":"A manageable and regulable inactivation function within the steroid binding domain of the glucorticoid receptor","volume":"54","author":"Picard","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2004.05.045_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0167-4781(91)90052-N","article-title":"The glucocortiocid receptor","volume":"1088","author":"Muller","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bmc.2004.05.045_bib58","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1016\/S0021-9258(20)89627-6","article-title":"The genomic structure of the human glucocorticoid receptor","volume":"266","author":"Encio","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2004.05.045_bib59","first-page":"459","article-title":"Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors","volume":"14","author":"Truss","year":"1993","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bmc.2004.05.045_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0167-4781(92)90501-P","article-title":"Interference of specific transcription factors","volume":"1129","author":"Ponta","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bmc.2004.05.045_bib61","first-page":"651","article-title":"Nuclear receptor\/AP-1 interaction","volume":"14","author":"Pfahl","year":"1993","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bmc.2004.05.045_bib62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/pupt.2001.0283","article-title":"Glucocorticoid-regulated transcription factors","volume":"14","author":"Adcock","year":"2001","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bmc.2004.05.045_bib63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Antiinflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin. Sci. (Colch.)"},{"key":"10.1016\/j.bmc.2004.05.045_bib64","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1073\/pnas.91.2.752","article-title":"Physical association and functional antagonism between the p65 subunit of transcription factor NF-kB and the glucocorticoid receptor","volume":"91","author":"Ray","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bmc.2004.05.045_bib65","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-KB, a pivotal transcription factor in chronic inflammation","volume":"336","author":"Barnes","year":"1997","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bmc.2004.05.045_bib66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-6147(97)89796-9","article-title":"NF-kB: a pivotal role in asthma and a new target for therapy","volume":"18","author":"Barnes","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bmc.2004.05.045_bib67","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1164\/ajrccm\/141.3.765","article-title":"Cytokines of the lung","volume":"141","author":"Kelley","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.bmc.2004.05.045_bib68","first-page":"S70","article-title":"Effect of corticosteroids on airway hyperresponsiveness","volume":"141","author":"Barnes","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.bmc.2004.05.045_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-4731(88)90080-5","article-title":"Glucocorticoid effects on the production and actions of immune cytokines","volume":"30","author":"Guyre","year":"1988","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bmc.2004.05.045_bib70","first-page":"S44","article-title":"Pharmacology and pharmacokinetics of topical corticosteroid derivatives used for asthma therapy","volume":"141","author":"Check","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.bmc.2004.05.045_bib71","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.305.6854.598","article-title":"Large volume plastic spacers in asthma","volume":"305","author":"Keeley","year":"1992","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bmc.2004.05.045_bib72","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003495-199447020-00007","article-title":"Inhaled fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in asthma","volume":"47","author":"Holliday","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2004.05.045_bib73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0091-6749(80)90200-6","article-title":"Candidiasis and dysphonia complicating beclomethasone treatment of asthma","volume":"65","author":"Toogood","year":"1980","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bmc.2004.05.045_bib74","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1183\/09031936.95.08040590","article-title":"Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations","volume":"8","author":"Williamson","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bmc.2004.05.045_bib75","first-page":"S89","article-title":"Complications of topical steroid therapy for asthma","volume":"141","author":"Toogood","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.bmc.2004.05.045_bib76","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003495-198428020-00002","article-title":"Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis","volume":"28","author":"Brogden","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2004.05.045_bib77","first-page":"35","article-title":"Dosing regimen of budesonide and occurrence of oropharyngeal complications","volume":"65","author":"Toogood","year":"1984","journal-title":"Eur. J. Respir. Dis."},{"key":"10.1016\/j.bmc.2004.05.045_bib78","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/pupt.2001.0284","article-title":"New glucocorticosteroids with an improved therapeutic ratio","volume":"14","author":"Belvisi","year":"2001","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bmc.2004.05.045_bib79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/1523-1747.ep12543603","article-title":"Corticosteroid atrophy in human skin. A study by light scanning and transmission electron microscopy","volume":"81","author":"Lehaman","year":"1983","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bmc.2004.05.045_bib80","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/jid.1982.14","article-title":"Regulation of collagen synthesis","volume":"79","author":"Pinnell","year":"1982","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bmc.2004.05.045_bib81","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/thx.45.8.573","article-title":"Corticosteroids and osteoporosis","volume":"45","author":"Smith","year":"1990","journal-title":"Thorax"},{"key":"10.1016\/j.bmc.2004.05.045_bib82","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2265.1989.tb03730.x","article-title":"Pathogenesis and treatment of steroid osteoporosis","volume":"30","author":"Reid","year":"1989","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bmc.2004.05.045_bib83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198308043090502","article-title":"Steroid-induced fracture and bone loss in patients with asthma","volume":"309","author":"Adinoff","year":"1983","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bmc.2004.05.045_bib84","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780280402","article-title":"Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatoid diseases","volume":"28","author":"Dykman","year":"1985","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bmc.2004.05.045_bib85","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/adc.67.6.703","article-title":"Asthma, inhaled corticosteroid treatment and growth","volume":"67","author":"Ninan","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bmc.2004.05.045_bib86","first-page":"S236","article-title":"An evaluation of the effects of beclomethasone dipropionate aqueous nasal spray [vancenase AQ (VNS)] on long-term growth in children [abstract]","volume":"101","author":"Rachelefsky","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bmc.2004.05.045_bib87","first-page":"415","article-title":"Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate","volume":"105","author":"Skoner","year":"2000","journal-title":"Pediatre"},{"key":"10.1016\/j.bmc.2004.05.045_bib88","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2222.1982.tb02541.x","article-title":"Linear growth of chronic asthmatic children: effects of disease and various forms of steroid therapy","volume":"12","author":"Chang","year":"1982","journal-title":"Clin. Allergy"},{"key":"10.1016\/j.bmc.2004.05.045_bib89","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/014107688307600604","article-title":"Effect of different corticosteroid regimens on hypothalamic-pituitary-adrenal axis and growth in juvenile chronic arthritis","volume":"76","author":"Byron","year":"1983","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.bmc.2004.05.045_bib90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1651-2227.1990.tb11335.x","article-title":"Long term treatment with glucocorticoids\/ACTH in asthmatic children","volume":"79","author":"Oberger","year":"1990","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.bmc.2004.05.045_bib91","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/adc.43.231.556","article-title":"Effect on height of corticosteroid therapy in asthmatic children","volume":"43","author":"Kerrebijn","year":"1968","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bmc.2004.05.045_bib92","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.1997.03540330044033","article-title":"Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma","volume":"277","author":"Garbe","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.bmc.2004.05.045_bib93","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0091-6749(98)70268-4","article-title":"Efficacy of inhaled corticosteroids in asthma","volume":"102","author":"Barnes","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bmc.2004.05.045_bib94","first-page":"455","article-title":"Steroid resistance in asthma","volume":"88","author":"Barnes","year":"1995","journal-title":"Quart. J. Med."},{"key":"10.1016\/j.bmc.2004.05.045_bib95","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.4049\/jimmunol.151.7.3460","article-title":"Combination IL-2 and IL-4 reduces glucocorticoid receptor binding affinity and T cell response to glucocorticoids","volume":"151","author":"Kam","year":"1993","journal-title":"J. Immonol."},{"key":"10.1016\/j.bmc.2004.05.045_bib96","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/sj.bjp.0702631","article-title":"IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNF\u03b1 production by human mononuclear blood cells","volume":"127","author":"Larsson","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bmc.2004.05.045_bib97","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.4049\/jimmunol.154.7.3500","article-title":"Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma","volume":"154","author":"Adcock","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.bmc.2004.05.045_bib98","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.182.6.1951","article-title":"Abnormal glucocorticoid receptor\u2013activator protein 1 interaction in steroid-resistant asthma","volume":"182","author":"Adcock","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bmc.2004.05.045_bib99","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1172\/JCI2680","article-title":"Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes","volume":"102","author":"Lane","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bmc.2004.05.045_bib100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0091-6749(99)70325-8","article-title":"In vivo resistance to corticoisteorids in bronchial asthma is associated with enhanced phosphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-Terminal Kinase phosphorylation","volume":"104","author":"Sousa","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bmc.2004.05.045_bib101","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0300-9084(91)90074-B","article-title":"Regulation of glucocorticoid receptor expression","volume":"73","author":"Okret","year":"1991","journal-title":"Biochimie"},{"key":"10.1016\/j.bmc.2004.05.045_bib102","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/S0021-9258(18)69104-5","article-title":"Mechanism of glucocorticoid receptor down-regulation by glucocorticoids","volume":"263","author":"Rosewicz","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2004.05.045_bib103","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1164\/ajrccm.154.3.8810618","article-title":"Glucocorticoid receptor localization in normal and asthmatic lung","volume":"154","author":"Adcock","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bmc.2004.05.045_bib104","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1164\/ajrccm.158.3.9710085","article-title":"Glucocorticoid receptors in bronchial epithelial cells in asthma","volume":"158","author":"Vachier","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bmc.2004.05.045_bib105","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1592\/phco.21.4.38S.34260","article-title":"Clinical considerations in the use of inhaled corticosteroids for asthma","volume":"21","author":"Williams","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bmc.2004.05.045_bib106","first-page":"353","article-title":"Easyhaler\u00ae, a novel multidose powder inhaler-comparison with metered dose inhaler","volume":"32","author":"Silvasti","year":"1996","journal-title":"Drugs Today"},{"key":"10.1016\/j.bmc.2004.05.045_bib107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2500\/108854101778250634","article-title":"Management and Treatment of Pediatric Asthma: Update","volume":"22","author":"Skoner","year":"2001","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.bmc.2004.05.045_bib108","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1345\/aph.17014","article-title":"Comparison of inhaled corticosteroids","volume":"32","author":"Kelly","year":"1998","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bmc.2004.05.045_bib109","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0954-6111(94)90044-2","article-title":"Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children","volume":"88","author":"Agertoft","year":"1994","journal-title":"Respir. Med."},{"key":"10.1016\/j.bmc.2004.05.045_bib110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0091-6749(97)70072-1","article-title":"Attained adult height after childhood asthma: effect of glucosteroid therapy","volume":"99","author":"Silverstein","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bmc.2004.05.045_bib111","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199707033370102","article-title":"Use of inhaled corticosteroids and the risk of cataracts","volume":"337","author":"Cumming","year":"1997","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bmc.2004.05.045_bib112","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.282.7.671","article-title":"Glucocorticoid-influenced adrenal insufficiency","volume":"282","author":"Krasner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bmc.2004.05.045_bib113","unstructured":"Guidelines for the diagnosis and management of asthma. Expert Panel Report II. NIH Publication no 97-4051; National Institutes of Health, Bathesda, MD, 1997"},{"key":"10.1016\/j.bmc.2004.05.045_bib114","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0091-6749(96)80198-9","article-title":"The effect of drug therapy on long-term outcomes of childhood asthma: a possible preview of the international guidelines","volume":"98","author":"Konig","year":"1996","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089604006911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089604006911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:47:58Z","timestamp":1760827678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089604006911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":114,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0968089604006911"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2004.05.045","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroids: the mainstay in asthma therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2004.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}